1Viegi G, Scognamiglio A, Baldicci S. Epidemiology of chronic obstructive pulmonary disease (COPD), Respiration, 2001,68: 4-19.
2Wouters EF. Economic analysis of the confronting COPD survey:an overview of results. Respir Med,2003,97(Suppl C):3-14.
3Pauwels RA. Buist AS,Calverley PM,et al. Global strategy for the diagnosis, Management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global initiative for chronic obstructive lung disease(GOLD) workshop summary[J], Am J Respir Crit Care Med,2001,163:1256-1276.
5Keatings VM, Collins PD, Scoee DM, et al. Differences of interleukin-8 and tumordisease of asthma. J Respir Crit Care Med,1996,153:530-534.
6Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J, 1998,12: 380-386.
7Turato G, LuinR, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema, Am J Respir crit car Med,2002,116105-110.
8Saetta M,Baraldo S,corbino L,et al, CD8+ve cells in the lungs of smokers,with chronic obstructive pulmonary disease[J], Am J Respir Crit care Med,1999,160:711-717.
9O'shoughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T-lymphocytes with FEV1. Am J Respir Crit Care Med,1997,155:852-857.
10Retamales I, Elliott WM, Meshi B, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection, Am J Respir Crit Care Med, 2001,164:469-473.
